|Table of Contents|

Application value of multidisciplinary team pattern in diagnosis and treatment for glioblastoma multiforme

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 04
Page:
643-647
Research Field:
Publishing date:

Info

Title:
Application value of multidisciplinary team pattern in diagnosis and treatment for glioblastoma multiforme
Author(s):
SHI Ji12ZHANG Ye2SUN Peixin2YAO Bing2HAO Yuanyuan2PIAO Haozhe2
1.Graduate School,Dalian Medical University,Liaoning Dalian 116000,China;2.Department of Neurosurgery,Cancer Hospital of China Medical University,Liaoning Cancer Hospital & Institute,Liaoning Shenyang 110042,China.
Keywords:
multidisciplinary teamglioblastoma multiformepatients' satisfactionoverall survival
PACS:
R730.264
DOI:
10.3969/j.issn.1672-4992.2023.04.009
Abstract:
Objective:To investigate the application value of MDT in the diagnosis and treatment of patients with glioblastoma multiforme(GBM).Methods:253 GBM patients hospitalized in neurosurgery between January 2015 and January 2018 from Liaoning Cancer Hospital & Institute were selected.According to the pattern of diagnosis and treatment,they were divided into MDT group(n=182) and non-MDT group(n=71).Several information such as the general information,patients' satisfaction,wait time before treatment,progression-free survival (PFS) and overall survival (OS) was compared between the two groups.Results:Patients' satisfaction was higher in the MDT group than in the non-MDT group,and the difference was statistically significant(P<0.01).The waiting time before treatment was shorter in the MDT group than in the non-MDT group,for (18.20±4.26) days and (21.66±3.52) days respectively,and the difference was statistically significant(P<0.05).The PFS in the MDT group and non-MDT group was 10.42 and 9.72 months,respectively,and the difference was not statistically significant.The OS in MDT and non-MDT groups was 19.11 months and 15.86 months respectively,and the difference was statistically significant(P<0.05).Conclusion:MDT is the best pattern for diagnosis and treatment of GBM patients,shortening the waiting time before treatment,improving patients' satisfaction,besides improving their overall survival to a certain extent.

References:

[1]DAVID NL,ARIE P,PIETER W,et al.The 2021 WHO classification of tumors of the central nervous system:a summary [J].Neuro Oncol,2021,23(8):1231-1251.
[2]GUO X,PIAO HZ.Research progress of circRNAs in glioblastoma [J].Front Cell Dev Biol,2021,9:791892.
[3]ZHAO MN,DEMIAN VS,MARIKE LD,et al.Nanocarrier-based drug combination therapy for glioblastoma [J].Theranostics,2020,10(3):1355-1372.
[4]DANIEL JD,SUSANNAH H,CHRISTOPHER H,et al.Multidisciplinary team decisions in management of abdominal aortic aneurysm:a service and quality evaluation[J].EJVES Vasc Forum,2022,54:49-53.
[5]LEJLA K,HARM HA,DOENJA MJL,et al.The effects of multidisciplinary team meetings on clinical practice for colorectal,lung,prostate and breast cancer:A systematic review [J].Cancers (Basel),2021,13(16):4159.
[6]BYDDER S,NOWAK A,MARION K,et al.The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non-small cell lung cancer [J].Intern Med J,2009,39(12):838-841.
[7]张琼,孔胜男,李沂泽,等.思维导图联合多学科团队教学模式在肝癌临床教学中的应用[J].现代肿瘤医学,2021,29(9):1603-1606. ZHANG Q,KONG SN,LI YZ,et al.Application of mind mapping combined with multidisciplinary team teaching model in clinical teaching of liver cancer[J].Modern Oncology,2021,29(9):1603-1606.
[8]ONKAR VK,THERESA G,DANA CN,et al.Socioeconomic risk factors for long-term mortality after pulmonary resection for lung cancer:an analysis of more than 90,000 patients from the national cancer data base [J].J Am Coll Surg,2015,220(2):156-168.
[9]MANILYN AH,ABDELSIMAR TO,KATHLEEN JK,et al.Socioeconomic factors affecting survivorship of glioblastoma patients in the Philippines [J].J Clin Neurosci,2022,98:89-95.
[10]国家卫生健康委员会医政医管局.脑胶质瘤诊疗规范(2018年版) [J].中华神经外科杂志,2019,35:217-239. National Health Commission Medical Administration.Diagnosis and treatment of brain glioma(2018)[J].Chinese Journal of Neurosurgery,2019,35:217-239.
[11]CHRIS I,MARTIN H,GORDON P,et al.Delay in radiotherapy shortens survival in patients with high grade glioma [J].J Neurooncol,2007,85(3):339-343.
[12]ELIOT LF,ROBERT JK,BRIAN JP,et al.Effectiveness of a thoracic multidisciplinary clinic in the treatment of stage III non-small-cell lung cancer [J].J Neurooncol,2016,9:267-274.
[13]MICHAEL W,MARTIN DB,MATTHIAS P,et al.EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood [J].Nat Rev Clin Oncol,2021,8(3):170-186.
[14]BRINDHA P,ADDIE CW,HELEN C,et al.The impact of multidisciplinary team meetings on patient assessment,management and outcomes in oncology settings:A systematic review of the literature [J].Cancer Treat Rev,2016,42:56-72.
[15]GEORGE TF,HILARY LB,ALASTAIR LY.Quality and efficacy of multidisciplinary team (MDT) quality assessment tools and discussion checklists:a systematic review[J].BMC Cancer,2022,22(1):286.
[16]SIMONA G,CAROLINA G,FRANCESCA M,et al.Neuro-oncology multidisciplinary tumor board:the point of view of the neuroradiologist [J].J Pers Med,2022,12(2):135.
[17]SONJA E,PAUL WD,VIVAN H,et al.Regional differences in breast cancer survival despite common guidelines [J].Cancer Epidemiol Biomarkers Prev,2005,14(12):2914-2918.
[18]SHAMI A,JOS PL,PRIYA PS,et al.Low-grade glioma case series:lessons learned from an evolving 10-year single-institution multidisciplinary team practice [J].World Neurosurg,2021,151:e47-e57.
[19]MALAKA A,DOROTHEA M,WAYNE NG,et al.A single-institution prospective evaluation of a neuro-oncology multidisciplinary team meeting [J].J Clin Neurosci,2018,56:127-130.
[20]MICHAEL FB,EMILY LL,WAIHOE NG,et al.Improvements in quality of care resulting from a formal multidisciplinary tumour clinic in the management of high-grade glioma [J].Ann Acad Med Singap,2007,36(5):347-351.

Memo

Memo:
辽宁省自然科学基金项目(编号:2020-ZLLH-37);辽宁省“兴辽英才计划”项目(编号:XLYC1902023)
Last Update: 1900-01-01